Journal of Medical Screening

Papers
(The TQCC of Journal of Medical Screening is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa46
“DNA tests for every baby on the NHS”34
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening28
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review24
Risk stratification in medical screening23
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms20
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway–Impact on radiologist person-years, costs and effects19
Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China18
Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health18
Cell-free DNA screening for sex chromosome aneuploidy in 67,099 pregnancies: A retrospective analysis17
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality16
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes14
Thanks to reviewers10
Timely adherence to follow-up after high-risk lung cancer screenings10
Applying the healthcare failure mode and effects analysis approach to improve the quality of an organised colorectal cancer screening programme9
Percentage mammographic density or absolute breast density for risk stratification in breast screening: Possible implications for socioeconomic health disparity9
Equity challenges in bowel cancer screening: A decade of spoilt faecal immunochemical test kit data in New Zealand8
Universal newborn hearing screening in Malaysian public hospitals: A national evaluation of coverage, quality indicators, and outcomes (2022–2023)8
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study7
The Risk-Screening Converter: Use of multiple risk factors7
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing7
Response to the letter: “Ethics of screening promotion: A slippery slope to forced marketing?”7
Effects of COVID-19 pandemic on breast cancer screening: A 6-year cohort study7
Folic acid and neural tube defects: Discovery, debate and the need for policy change6
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening6
The Risk-Screening Converter6
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis6
Cancer screening after the age of 75: Nationwide population-based trends6
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines6
Cancer screening programs in Japan: Progress and challenges6
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis5
Trends in colorectal cancer screening in the United States, 2012 to 20205
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada5
Comments on “Effects of COVID-19 pandemic on breast cancer screening” by Huang et al. https://doi.org/10.1177/096914132513384565
Age at breast cancer screening in women with intellectual disability5
Positive predictive value metrics for multicancer detection tests5
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study5
Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection de4
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test4
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue4
Colorectal cancer screening with faecal immunochemical test: Patterns of participation4
Response to ‘Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change’4
Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines4
The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy4
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India4
Quality indicators for cervical screening in Sweden4
Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010–20194
0.60917496681213